Abeona Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABEO and other ETFs, options, and stocks.About ABEO
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB).
CEOVishwas Seshadri
CEOVishwas Seshadri
Employees136
Employees136
HeadquartersCleveland, Ohio
HeadquartersCleveland, Ohio
Founded1974
Founded1974
Employees136
Employees136
ABEO Key Statistics
Market cap282.55M
Market cap282.55M
Price-Earnings ratio-2.57
Price-Earnings ratio-2.57
Dividend yield—
Dividend yield—
Average volume2.00M
Average volume2.00M
High today$5.91
High today$5.91
Low today$5.31
Low today$5.31
Open price$5.36
Open price$5.36
Volume2.01M
Volume2.01M
52 Week high$7.32
52 Week high$7.32
52 Week low$3.93
52 Week low$3.93
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ABEO. This list is generated using Robinhood data, and it’s not a recommendation.